Neutralizing activity of anti-SARS-CoV-2 hyperimmune immunoglobulins and intravenous immunoglobulins against currently circulating SARS-CoV-2 variants.

ABSTRACT:

SUBMITTER: Bellusci L 

PROVIDER: S-EPMC11473157 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature